These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 10936085)

  • 1. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
    Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
    J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
    Pletnev AG
    Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
    Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
    Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4.
    Pletnev AG; Men R
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1746-51. PubMed ID: 9465088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice.
    Rumyantsev AA; Murphy BR; Pletnev AG
    J Virol; 2006 Feb; 80(3):1427-39. PubMed ID: 16415020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy.
    Pletnev AG; Putnak R; Speicher J; Wagar EJ; Vaughn DW
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3036-41. PubMed ID: 11880643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.
    Wright PF; Ankrah S; Henderson SE; Durbin AP; Speicher J; Whitehead SS; Murphy BR; Pletnev AG
    Vaccine; 2008 Feb; 26(7):882-90. PubMed ID: 18207289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious cDNA clones of Langat tick-borne flavivirus that differ from their parent in peripheral neurovirulence.
    Campbell MS; Pletnev AG
    Virology; 2000 Mar; 269(1):225-37. PubMed ID: 10725214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic immunization against tick-borne encephalitis virus].
    Mitrofanova EE; Bakhvalova VN; Dobrikova EIu; Pap VA; Morozova OV
    Mol Biol (Mosk); 1997; 31(3):403-6. PubMed ID: 9297083
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.
    Hanley KA; Manlucu LR; Manipon GG; Hanson CT; Whitehead SS; Murphy BR; Blaney JE
    Vaccine; 2004 Sep; 22(25-26):3440-8. PubMed ID: 15308370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
    Lai CJ; Monath TP
    Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.
    Aberle JH; Aberle SW; Kofler RM; Mandl CW
    J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.